Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-up
Eva L Kneepkens, James Cheng-Chung Wei, Michael T Nurmohamed, Kai-Jieh Yeo, C Y Chen, Irene E van der Horst-Bruinsma, Desiree van der Kleij, Theo Rispens, Gertjan Wolbink, Charlotte L M Krieckaert
Annals of the Rheumatic Diseases Feb 2015, 74 (2) 396-401; DOI: 10.1136/annrheumdis-2013-204185